Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

SBC vs RYOJ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SBC Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 8–2 Matrix Metrics)

SBC Overall Winner 6-Pillar Tally: SBC 4 – 1 RYOJ (1 Tie) Matrix Metrics: SBC 8 – 2 RYOJ

As of Nov 19, 2026, SBC Medical Group Holdings Incorporated (SBC) is the stronger overall head-to-head candidate over rYojbaba Co., Ltd. Common Shares (RYOJ) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SBC carries a Unified Composite Score of 38.7/100 (SELL) at $5.60 (10.2x Forward P/E, 39.9% operating margin), whereas RYOJ carries 42.9/100 (HOLD) at $2.23 (N/M Forward P/E, -8.1% operating margin).

  • Composite vs. Pillar Nuance: While RYOJ currently prints a higher short-term Unified Composite Score (42.9/100 HOLD vs. SBC 38.7/100 SELL), SBC captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.9% vs. -8.1% operating margin) and revenue trajectory (+35.1% vs. -34.3% YoY).
  • Technical & Structure Timing Caution: SBC trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 50.8); meanwhile RYOJ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SBC vs RYOJ
SBC NASDAQ Head-to-Head Winner
SBC Medical Group Holdings Incorporated Common Stock
Services-Offices & Clinics Of Doctors Of Medicine
$5.60
-10.69% 1D
Market Cap $643.2M
TTM Revenue $190M
Forward P/E 10.2x
Beta / 30D Vol 0.80β · 156% Vol
Unified Composite Score
38.7 / 100 SELL
Tech 15.0 Fund 29.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (13.1% over 20 days), RSI 51
RSI-14: 50.8 · SMA20: $5.54 · SMA50: $5.26
RYOJ NASDAQ
rYojbaba Co., Ltd. Common Shares
Services-Management Consulting Services
$2.23
-0.89% 1D
Market Cap $26.0M
TTM Revenue $9.3M
Forward P/E N/M
Beta / 30D Vol 1.68β · 92% Vol
Unified Composite Score
42.9 / 100 HOLD
Tech 23.0 Fund 50.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -26.4%), weak momentum, RSI 37
RSI-14: 37.3 · SMA20: $2.45 · SMA50: $2.95

6-Pillar Scorecard Institutional Category Breakdown (SBC 4 – 1 RYOJ)

Columns: Metric · SBC · RYOJ
1. Valuation Multiples SBC
Forward P/E 10.2x N/M
Trailing P/E 12.3x N/M
PEG Ratio 2.35x N/M
EV / Revenue 3.4x 2.8x
2. Growth & Scale SBC
Revenue Growth (YoY) +35.1% -34.3%
Earnings Growth (YoY) +22.4% +11.8%
TTM Revenue (USD) $190M $9.3M
Market Cap $643.2M $26.0M
3. Profitability & Quality SBC
Gross Margin 72.2% 26.6%
Operating Margin 39.9% -8.1%
Net Profit Margin 27.3% 1.3%
Return on Equity (ROE) 19.3% 2.8%
4. Balance Sheet & Cash Flow SBC
Cash Generation (TTM) $80M EBITDA -$59,921 EBITDA
Cash Flow Margin 41.8% EBITDA Mgn -0.6% EBITDA Mgn
Net Cash / Leverage $2.79 Book/Sh · 19.3% ROE $0.53 Book/Sh · 2.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat RYOJ
OpEx & R&D Intensity 32.3% of Rev ($61M) 34.7% of Rev ($3.2M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Consulting Services Operator Consulting Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SBC (8) vs RYOJ (2)
Institutional Metric SBC RYOJ Criterion Row Edge
Market Capitalization
Scale
$643.2M $26.0M Larger Scale SBC
Trailing P/E Ratio
Valuation
12.3x N/M Lower Multiple SBC
Forward P/E Ratio
Valuation
10.2x N/M Lower Multiple SBC
Revenue Growth (YoY)
Growth
+35.1% -34.3% Higher Growth SBC
Operating Margin (TTM)
Profitability
39.9% -8.1% Higher Margin SBC
Net Profit Margin
Profitability
27.3% 1.3% Higher Margin SBC
Return on Equity (ROE)
Capital Efficiency
19.3% 2.8% Higher ROE SBC
52-Week Range Position
Momentum
61% ($3–$7) 10% ($2–$8) Stronger Trend SBC
Beta / 30D Volatility
Risk Regime
0.80β · 156% Vol 1.68β · 92% Vol Lower Realized Risk RYOJ
Unified Institutional Score
Composite Signal
38.7 / 100 (SELL) 42.9 / 100 (HOLD) Higher Composite RYOJ
Trailing 12M Revenue (USD)
Operating Scale
$190M $9.3M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
72.2% 26.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.35x PEG · 3.4x EV/Rev N/M PEG · 2.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$80M EBITDA ($2.79 Book/Sh · 19.3% ROE) -$59,921 EBITDA ($0.53 Book/Sh · 2.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SBC +12.59 pp
SBC: +1.08% · RYOJ: -11.51%
3M Horizon SBC +104.83 pp
SBC: +52.17% · RYOJ: -52.66%
6M Horizon SBC +59.6 pp
SBC: +73.37% · RYOJ: +13.77%
1Y Horizon SBC +126.32 pp
SBC: +76.66% · RYOJ: -49.66%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SBC vs RYOJ. Trailing 12-month operating profitability (SBC 39.9% vs RYOJ -8.1%) and valuation multiples (SBC 10.2x vs RYOJ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

SBC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$190M
Gross Margin72.2%
Op. Margin39.9%
ROE / Fwd P/E19.3% · 10.2x
RYOJ ADR TTM Benchmark FX-Normalized USD
TTM Revenue$9.3M
Gross Margin26.6%
Op. Margin-8.1%
ROE / Fwd P/E2.8% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SBC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SBC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
RYOJ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RYOJ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SBC Moat Profile High-Margin Pricing Power Moat
Consulting Services Operator
Competes within the Consulting Services value chain with $643.2M market capitalization and 39.9% operating margin.
OpEx & R&D Reinvestment 32.3% of Rev ($61M)
90D Engineering Disclosures 0 Published
RYOJ Moat Profile Cyclical / Execution-Driven Positioning
Consulting Services Operator
Competes within the Consulting Services value chain with $26.0M market capitalization and -8.1% operating margin.
OpEx & R&D Reinvestment 34.7% of Rev ($3.2M)
90D Engineering Disclosures 0 Published

Investor FAQ SBC vs RYOJ Key Questions & Quantitative Answers

As of Nov 19, 2026, SBC Medical Group Holdings Incorporated (SBC) is the stronger overall head-to-head candidate over rYojbaba Co., Ltd. Common Shares (RYOJ) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). SBC carries a Unified Composite Score of 38.7/100 (SELL) at $5.60 (10.2x Forward P/E, 39.9% operating margin), whereas RYOJ carries 42.9/100 (HOLD) at $2.23 (N/M Forward P/E, -8.1% operating margin). Composite vs. Pillar Nuance: While RYOJ currently prints a higher short-term Unified Composite Score (42.9/100 HOLD vs. SBC 38.7/100 SELL), SBC captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (39.9% vs. -8.1% operating margin) and revenue trajectory (+35.1% vs. -34.3% YoY). Technical & Structure Timing Caution: SBC trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 50.8); meanwhile RYOJ is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.3). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SBC leads the Growth & Scale pillar: SBC posts +35.1% YoY revenue growth and +22.4% YoY earnings growth on $190M TTM revenue (72.2% gross margin, 39.9% operating margin), compared with RYOJ at -34.3% YoY revenue growth and +11.8% YoY earnings growth on $9.3M TTM revenue (26.6% gross margin, -8.1% operating margin). On trailing 12-month operating scale, SBC generates $190M in USD-normalized revenue versus $9.3M for RYOJ. In operating R&D and SG&A reinvestment, SBC deploys 32.3% of Rev ($61M) (0 90-day corporate R&D disclosures) versus 34.7% of Rev ($3.2M) (0 disclosures) for RYOJ.

SBC screens cheaper on headline valuation multiples. SBC trades at 10.2x Forward P/E, 12.3x Trailing P/E, 2.35x PEG, and 3.4x EV/Revenue (41.8% EBITDA margin), whereas RYOJ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 2.8x EV/Revenue (-0.6% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SBC (19.3% ROE) versus RYOJ (2.8% ROE) capital efficiency.

In options market volatility and institutional positioning, SBC carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.80β · 156% Vol realized risk). By comparison, RYOJ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.68β · 92% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.